Bis-pyrazolines: Synthesis, characterization and antiamoebic activity as inhibitors of growth of Entamoeba histolytica

European Journal of Medicinal Chemistry

Volumn 44, Issue 1, 2009, Pages 426-431

  Bhat, Abdul R ^a   Athar, Fareeda ^a   Azam, Amir ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Antiamoebic activity; Bis Pyrazolines; Bischalcone; Thiocarbamoyl

Indexed keywords

(4 NITROPHENYLAMINO)[5 (4 {1 [(4 NITROPHENYLAMINO) THIOXOMETHYL] 3 PHENYL(2 PYRAZOLINE 5 YL PHENYL)} 3 PHENYL(2 PYRAZOLINYL)]METHANE 1 THIONE; [(2,4 DIFLUOROPHENYL)AMINO[5 (4 {1 {[(2,4 DIFLUOROPHENYL)AMINO]THIOXOMETHYL} 3 PHENYL(2 PYRAZOLINE 5 YL PHENYL)} 3 PHENYL(2 PYRAZOLINYL)]METHANE 1 THIONE; ANTIAMEBIC AGENT; CHALCONE; METRONIDAZOLE; PYRAZOLINE DERIVATIVE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG PURITY; DRUG SYNTHESIS; ENTAMOEBA HISTOLYTICA; GROWTH INHIBITION; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

AMEBICIDES; ANIMALS; CELL LINE; ENTAMOEBA HISTOLYTICA; EPITHELIAL CELLS; HUMANS; INHIBITORY CONCENTRATION 50; KIDNEY; MOLECULAR STRUCTURE; PARASITIC SENSITIVITY TESTS; PYRAZOLES; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57949084788     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.11.005     Document Type: Article

References (28)

1. Stanley Jr. S.L. Lancet 361 (2003) 1025-1034
2. WHO. Wkly. Epidemiol. Rec. 14 (1997) 97-100
3. Huston C.D., Haque R., and Petri Jr. W.A. Expert Rev. Mol. Med. (1999) 1-11
4. Ravdin J.L. Clin. Infect. Dis. 20 (1995) 1453-1466
5. Rocco F.D., Sabatino G., Tamburrini G., Ranno O., Valentini P., and Caldarlli M. Acta Neurochir. 146 (2004) 1271-1272
6. Ng D.C.K., Kwok S.Y., Cheng Y., Chung C.C., and Li M.K.W. Hong Kong Med. J. 12 (2006) 71-73
7. Azam A., and Agarwal S.M. Curr. Bioact. Compd. 3 (2007) 121-123
8. Roe F. Surgery 93 (1983) 158-164
9. Samuelson J.C., Burke A., and Courval J.M. Antimicrob. Agents Chemother. 36 (1992) 2392-2397
10. Adagu I.S., Nolder D., Warhurst D.C., and Rossignol J.F. J. Antimicrob. Chemother. 49 (2002) 103-111
11. Turan-Zitouni G., Ozdemir A., and Guven K. Arch. Pharm. (Weinheim) 338 (2005) 96-104
12. Gokhan N., Yesilada A., Ucar G., Erol K., and Bilgin A.A. Arch. Pharm. Med. Chem. 336 (2003) 362-371
13. Holla B.S., Akbarali P.M., and Shivanada M.K. IL Farmaco 55 (2000) 256-263
14. Prassad Y.R., Rao A.L., Prasoona L., Murali K., and Kumar P.R. Bioorg. Med. Chem. Lett. 15 (2005) 5030-5034
15. Zitouni J.T., Chevallet P., Kilic F.S., and Erol K. Eur. J. Med. Chem. 35 (2000) 635-641
16. Bruno O., Ranise A., Bondavalli F., Schenone F., D' Amico M., Filipelli A., Filipelli W., and Francesco R. IL Farmaco 48 (1993) 949-966
17. Reddy D.B., Seenaiah B., Eswaraiah S., Seshamma T., and Reddy M.V.R. J. Indian Chem. Soc. 66 (1989) 893-896
18. Abid M., and Azam A. Bioorg. Med. Chem. 13 (2005) 2213-2220
19. Abid M., and Azam A. Bioorg. Med. Chem. Lett. 16 (2006) 2812-2816
20. Abid M., and Azam A. Eur. J. Med. Chem. 40 (2005) 935-942
21. O' Sullivan D.G., Sadler P.W., and Webley C. Chem. Commun. 7 1 (1963) 17-26
22. Ferres H., and Jackson W.R. J. Chem. Soc., D. Chem. Commun. 6 (1969) 261-262
23. Wiley R.H., Jarboe C.H., Hayes F.N., Hansbury E., Nielson J.T., Callahan P.X., and Sellars M.C. J. Org. Chem. 23 (1958) 732-738
24. Wright W., O'Neill M.J., Phillipson J.D., and Warhurst D.C. Antimicrob. Agents Chemother. 32 (1988) 1725-1729
25. Diamond L.S., Harlow D.R., and Cunnick C.C. Trans. R. Soc. Trop. Med. Hyg. 72 (1978) 431-432
26. Gillin F.D., Reiner D.S., and Suffness M. Antimicrob. Agents Chemother. 22 (1982) 342-345
27. Keen A.T., Harris A., Phillipson J.D., and Warhurst D.C. Planta Med. (1986) 278-284
28. Mosmann T. J. Immunol. Methods 65 1-2 (1983) 55-63